Safety and Efficacy of ATIR101 as Adjunctive Treatment to Blood Stem Cell Transplantation From a Haploidentical Family Donor Compared to Post-transplant Cyclophosphamide in Patients With Blood Cancer

Name: Safety and Efficacy of ATIR101 as Adjunctive Treatment to Blood Stem Cell Transplantation From a Haploidentical Family Donor Compared to Post-transplant Cyclophosphamide in Patients With Blood Cancer
Published: 2017
License: Public Domain

Kiadis Pharma · 2017

ClinicalTrials.gov · Datasets · License: Public Domain · 2017

Open Source ↗

acute-myeloid-leukemia overall-survival

acute myeloid leukemia, acute lymphoblastic leukemia, myelodysplastic syndrome, haploidentical stem cell transplantation, graft-versus-host disease, immune reconstitution, alloreactive t-cells, photodynamic treatment, hematologic malignancy, transplant-related mortality, overall survival, grfs

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 852972
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.